Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$538M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$251M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.39% |
| 2 | Financials | 7.95% |
| 3 | Communication Services | 5.87% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Healthcare | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
CBIZ
CBZ
$2.99B
| $453K | ﹤0.01% |
13,810
-35,388
| -72% | -$1.18M |
|
|
GOOD
3102
Gladstone Commercial Corp
GOOD
$608M
| $453K | ﹤0.01% |
20,105
-66,668
| -77% | -$1.42M |
|
|
SOL
3103
DELISTED
Emeren Group
SOL
| $452K | ﹤0.01% |
+49,707
| New | +$444K |
|
|
MRC
3104
DELISTED
MRC Global
MRC
| $451K | ﹤0.01% |
47,976
-188,020
| -80% | -$1.91M |
|
3105
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.47B
| $449K | ﹤0.01% |
+9,057
| New | +$449K |
|
3106
Clearwater Paper
CLW
$369M
| $447K | ﹤0.01% |
15,412
-11,095
| -42% | -$346K |
|
3107
Meridian
MRBK
$236M
| $446K | ﹤0.01% |
34,006
-6,214
| -15% | -$81.6K |
|
3108
Opko Health
OPK
$978M
| $446K | ﹤0.01% |
110,194
-285,599
| -72% | -$1.12M |
|
|
VTA
3109
DELISTED
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
| $446K | ﹤0.01% |
+36,312
| New | +$422K |
|
3110
Mid Penn Bancorp
MPB
$971M
| $445K | ﹤0.01% |
16,229
+3,876
| +31% | +$105K |
|
|
SURF
3111
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $444K | ﹤0.01% |
59,506
-33,142
| -36% | -$255K |
|
|
NP
3112
DELISTED
Neenah, Inc. Common Stock
NP
| $441K | ﹤0.01% |
8,789
-15,150
| -63% | -$808K |
|
3113
Spok Holdings
SPOK
$234M
| $439K | ﹤0.01% |
45,735
-8,401
| -16% | -$89.7K |
|
|
AVTA
3114
DELISTED
Avantax, Inc. Common Stock
AVTA
| $439K | ﹤0.01% |
25,385
-34,750
| -58% | -$571K |
|
3115
PJT Partners
PJT
$4.38B
| $438K | ﹤0.01% |
6,139
-16,336
| -73% | -$1.17M |
|
3116
Civista Bancshares
CIVB
$605M
| $437K | ﹤0.01% |
19,757
-11,052
| -36% | -$255K |
|
|
EVOP
3117
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $437K | ﹤0.01% |
15,767
-29,555
| -65% | -$843K |
|
3118
Allient
ALNT
$1.61B
| $435K | ﹤0.01% |
12,594
+3,408
| +37% | +$120K |
|
3119
Heartland Express
HTLD
$990M
| $435K | ﹤0.01% |
25,434
-36,378
| -59% | -$672K |
|
3120
National Presto Industries
NPK
$975M
| $433K | ﹤0.01% |
4,263
-2,319
| -35% | -$239K |
|
3121
MediciNova
MNOV
$64M
| $430K | ﹤0.01% |
101,160
+21,829
| +28% | +$94K |
|
3122
Prothena Corp
PRTA
$444M
| $429K | ﹤0.01% |
8,360
-21,137
| -72% | -$659K |
|
3123
TriMas Corp
TRS
$1.45B
| $428K | ﹤0.01% |
14,098
-29,906
| -68% | -$948K |
|
|
NVO
3124
Novo Nordisk
NVO
$196B
| $427K | ﹤0.01% |
10,194
-12,094
| -54% | -$469K |
|
3125
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.87B
| $426K | ﹤0.01% |
11,180
-53,406
| -83% | -$2.01M |
|
Similar funds
Barclays's Q2 2021 Portfolio in Review
As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.
- Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
- Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
- Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
- Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
- Barclays opened 558 new positions and closed 327 in Q2 2021.
- Barclays's portfolio value rose 14% quarter-over-quarter to $212B.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.